Abstract:Enteral absorption by healthy male volunteers of cis-5,8,11,14,17-eicosapentaenoic acid (20:5(n-3), EPA) and cis-4,7,10,13,16,19-docosahexaenoic acid (22:6(n-3), DHA) from an ethyl ester enriched in EPA and DHA (K85) and from natural fish oil (TG30) was found to be similar after intake of equivalent doses. Thus, after administration twice daily for 14 days, the amounts of EPA and DHA in total serum lipids and in serum phospholipids were essentially identical for the two ester forms of the n-3 fatty acids. A dose-dependent relationship between intake and total phospholipid serum levels was observed for EPA, which increased 6.5-12-fold and 4.8-9-fold, respectively, but DHA reached a plateau at 2-2.5-fold over the control after supplementation. Arachidonic acid (AA) did not change significantly in total serum lipids, but fell 10-20% in serum phospholipids. The supplementation resulted in a 6.3-11-fold increase in the EPA/AA ratio. A significant and dose-dependent 25-45% reduction in linoleic acid (18:2(n-6), LA) was found in serum phospholipids, while a smaller decrease was observed in total serum lipids. 20:3(n-6), 20:3(n-9) and 22:5(n-6) also decreased significantly in serum phospholipids. Saturated fatty acids remained essentially unchanged. Some 35-47% decrease in serum triacylglycerols and approx. 10% decrease in cholesterol levels were also observed. In spite of the similar serum levels of EPA and DHA obtained in vivo, in vitro hydrolysis by porcine pancreatic lipase of K85 was 3-fold slower than hydrolysis of a glyceryl ester (TG85) similarly enriched in EPA and DHA, and 15-fold slower than the hydrolysis of the 3-fold less enriched TG30 with EPA and DHA predominantly in the 2-position. Under similar conditions release of AA from glyceryl ester and ethyl ester was essentially similar and approx. 1.5-fold faster than release of EPA and DHA from ethyl esters. In vitro hydrolysis of olive oil was 1.8-fold faster than hydrolysis of a natural fish oil (TG30) under similar conditions. Thus, the order of the rates of hydrolyses was olive oil > TG30 > TG85 > triarachidonin > LA ethyl ester > AA ethyl ester > ethyl ester K85. Our results show that in spite of differences in the rate of hydrolysis by lipase in vitro, the enteral absorption of EPA and DHA is as least as good from a synthetic ethyl ester highly enriched in EPA and DHA as it is from a natural triacylglycerol containing equivalent amounts of these fatty acids.

Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters

Single-Dose SDA-Rich Echium Oil Increases Plasma EPA, DPAn3, and DHA Concentrations

The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro

Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood

Pure Omega 3 Polyunsaturated Fatty Acids (EPA, DPA or DHA) Are Associated with Increased Plasma Levels of 3-Carboxy-4-methyl-5-propyl-2-furanpropanoic Acid (CMPF) in a Short-Term Study in Women

Blood EPA and DHA status among people living in the United States from 2000 to 2023

Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial

Evaluation of the Metabolite Profile of Fish Oil Omega-3 Fatty Acids (n-3 FAs) in Micellar and Enteric-Coated Forms-A Randomized, Cross-Over Human Study

Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil

Systematic Metabolomic Analysis of Eicosanoids after Omega-3 Polyunsaturated Fatty Acid Supplementation by a Highly Specific Liquid Chromatography-Tandem Mass Spectrometry-Based Method.

Differential Anti-Adipogenic Effects of Eicosapentaenoic and Docosahexaenoic Acids in Obesity.

Human blood lipid profiles after dietary supplementation of different omega 3 ethyl esters formulations

Effect of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) on the regulation of vascular endothelial cell function

Bread enriched with microencapsulated tuna oil increases plasma docosahexaenoic acid and total omega-3 fatty acids in humans

Wax Ester Rich Oil From The Marine Crustacean, Calanus finmarchicus, is a Bioavailable Source of EPA and DHA for Human Consumption

APOE Genotype Modifies the Plasma Oxylipin Response to Omega-3 Polyunsaturated Fatty Acid Supplementation in Healthy Individuals

Bioavailability of Docosahexaenoic Acid 22:6(N-3) from Enantiopure Triacylglycerols and Their Regioisomeric Counterpart in Rats.

Post-Prandial Cognitive and Blood Pressure Effects of a DHA-Rich Omega-3 Powder in Middle-Aged Males: A Pilot Study

Dietary supplementation with seed oil from transgenic Camelina sativa induces similar increments in plasma and erythrocyte DHA and EPA to fish oil in healthy humans

Digestion, Absorption, and Metabolism Characteristics of EPA-Enriched Phosphoethanolamine Plasmalogens Based on Gastrointestinal Functions in Healthy Mice.

Comparing the Impact of Prescription Omega-3 Fatty Acid Products on Low-Density Lipoprotein Cholesterol